XTX Topco’s Propanc Biopharma PPCB Stock Holding History

XTX Topco’s Portfolio PPCB Stock Details PPCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-484	Closed	-$1.28K	–	4885
2026 Q1	$1.28K	Sell	484 -401	-45%	-$2.38K	﹤0.01%	3771
2025 Q4	$11.9K	Buy	+885	New	+$24.5K	﹤0.01%	3158

Other funds holding PPCB

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

XTX Topco's PPCB Position: Q2 2026 in Review

XTX Topco sold out of Propanc Biopharma (PPCB) in Q2 2026, closing a stake of 484 shares — an estimated $1.28K sold.

XTX Topco first reported a position in PPCB in Q4 2025 and held it in 2 quarters. The position peaked at $11.9K in Q4 2025. 4 funds tracked by Wall St. Rank hold PPCB as of Q2 2026.

XTX Topco reported no remaining Propanc Biopharma position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 484 Propanc Biopharma shares in Q2 2026, an estimated $1.28K.
XTX Topco first reported a position in Propanc Biopharma in Q4 2025 and held it in 2 quarters.
XTX Topco's Propanc Biopharma position peaked at $11.9K in Q4 2025.
4 funds tracked by Wall St. Rank held Propanc Biopharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.